These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8154021)

  • 21. Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.
    Kumano K; Nishinakamura H; Mera T; Itoh T; Takahashi H; Fujiwara T; Kodama S
    Islets; 2016 Sep; 8(5):145-55. PubMed ID: 27618231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
    Stock PG; Ascher NL; Chen S; Bumgardner GL; Field MJ; Sutherland DE
    J Surg Res; 1989 Apr; 46(4):317-21. PubMed ID: 2649742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
    Desai NM; Bassiri H; Kim J; Koller BH; Smithies O; Barker CF; Naji A; Markmann JF
    Transplantation; 1993 Apr; 55(4):718-22. PubMed ID: 8475541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
    Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
    Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts.
    Brown K; Nowocin AK; Meader L; Edwards LA; Smith RA; Wong W
    Am J Transplant; 2016 Apr; 16(4):1129-38. PubMed ID: 26799449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic islet transplantation. Induction of graft acceptance by ultraviolet irradiation of donor tissue.
    Hardy MA; Lau H; Weber C; Reemtsma K
    Ann Surg; 1984 Oct; 200(4):441-50. PubMed ID: 6237621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cryopreservation on the survival and MHC antigen expression of murine islet allografts.
    Cattral MS; Warnock GL; Kneteman NM; Halloran PF; Rajotte RV
    Transplantation; 1993 Jan; 55(1):159-63. PubMed ID: 8420042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both innate and adaptive major histocompatibility complex class I-dependent immunity impair long-term islet xenograft survival.
    Ramirez-Victorino F; Beilke JN; Gill RG
    Transplant Proc; 2008 Mar; 40(2):557-8. PubMed ID: 18374128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells.
    Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 2000 Jan; 69(2):221-6. PubMed ID: 10670630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha4 integrin in islet allograft rejection.
    Stegall MD; Dean PG; Ninova D; Cohen AJ; Shepard GM; Gup C; Gill RG
    Transplantation; 2001 Jun; 71(11):1549-55. PubMed ID: 11435963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival.
    Alejandro R; Latif Z; Noel J; Shienvold FL; Mintz DH
    Diabetes; 1987 Mar; 36(3):269-73. PubMed ID: 3100370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
    Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
    J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.